Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162169
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2023-11-29
Brief Title:
A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
Sponsor:
Jacobio Pharmaceuticals Co Ltd
Organization:
Jacobio Pharmaceuticals Co Ltd
Study Overview
Official Title:
A Single-center Non-randomized Open-lable Self-controlled Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase I study to evaluate drug-drug interactions DDIs of JAB-21822 as a perpetrator combined with midazolam rosuvastatin and digoxin and to evaluate DDIs of JAB-21822 as a victim combined with itraconazole rifampicin and omeprazole in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None